D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
PUT
Amgen
AMGN
$209B
| $6.7M | ﹤0.01% |
24,000
-147,500
| -86% | -$41.8M |
|
1702
Hillman Solutions
HLMN
$1.57B
| $6.7M | ﹤0.01% |
937,925
+723,890
| +338% | +$5.42M |
|
1703
Canadian Solar
CSIQ
$932M
| $6.7M | ﹤0.01% |
606,479
+23,411
| +4% | +$226K |
|
|
PLMK
1704
Plum Acquisition Corp IV
PLMK
$257M
| $6.7M | ﹤0.01% |
650,000
| – | – |
|
1705
CALL
ZIM Integrated Shipping Services
ZIM
$2.96B
| $6.68M | ﹤0.01% |
415,000
+90,000
| +28% | +$1.42M |
|
|
EB
1706
DELISTED
Eventbrite
EB
| $6.63M | ﹤0.01% |
2,520,082
+137,809
| +6% | +$317K |
|
1707
Heron Therapeutics
HRTX
$93.4M
| $6.62M | ﹤0.01% |
3,200,299
+214,102
| +7% | +$437K |
|
1708
CALL
StoneCo
STNE
$2.67B
| $6.62M | ﹤0.01% |
413,000
+298,600
| +261% | +$3.98M |
|
1709
PUT
Elevance Health
ELV
$81.5B
| $6.61M | ﹤0.01% |
17,000
-41,600
| -71% | -$16.7M |
|
1710
iShares MSCI Mexico ETF
EWW
$1.89B
| $6.61M | ﹤0.01% |
+109,183
| New | +$6.29M |
|
1711
Veeco
VECO
$2.62B
| $6.6M | ﹤0.01% |
324,976
-350,601
| -52% | -$6.92M |
|
1712
PUT
Procter & Gamble
PG
$340B
| $6.6M | ﹤0.01% |
41,400
+6,400
| +18% | +$1.04M |
|
1713
Gulfport Energy Corp
GPOR
$2.82B
| $6.59M | ﹤0.01% |
32,745
-84,249
| -72% | -$15.7M |
|
1714
Stoneridge
SRI
$200M
| $6.58M | ﹤0.01% |
934,282
-11,211
| -1% | -$54.9K |
|
1715
EPR Properties
EPR
$4.89B
| $6.57M | ﹤0.01% |
112,834
+99,547
| +749% | +$5.24M |
|
1716
PUT
Allegro MicroSystems
ALGM
$7.86B
| $6.57M | ﹤0.01% |
+192,100
| New | +$4.79M |
|
1717
Garrett Motion
GTX
$5.37B
| $6.57M | ﹤0.01% |
624,718
+612,746
| +5,118% | +$6.17M |
|
1718
PUT
Jabil
JBL
$30.1B
| $6.54M | ﹤0.01% |
30,000
| – | – |
|
1719
CALL
Wynn Resorts
WYNN
$10.3B
| $6.54M | ﹤0.01% |
69,800
+16,200
| +30% | +$1.37M |
|
1720
Logitech
LOGI
$14.8B
| $6.52M | ﹤0.01% |
72,335
-404,107
| -85% | -$32.8M |
|
1721
Newmark Group
NMRK
$2.64B
| $6.52M | ﹤0.01% |
536,300
+220,716
| +70% | +$2.47M |
|
1722
Maximus
MMS
$3.32B
| $6.5M | ﹤0.01% |
92,639
-30,476
| -25% | -$2.14M |
|
1723
PUT
Fortinet
FTNT
$112B
| $6.5M | ﹤0.01% |
61,500
-46,000
| -43% | -$4.64M |
|
1724
CALL
CRISPR Therapeutics
CRSP
$4.69B
| $6.5M | ﹤0.01% |
133,600
+82,200
| +160% | +$3.18M |
|
1725
PUT
Ares Management
ARES
$28.1B
| $6.5M | ﹤0.01% |
37,500
| – | – |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.